October 17, 2022 — At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly introduces Omni Legendi, the first system on its all-new, all-digital…
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...
February 23, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of ...
February 16, 2023 — TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
February 9, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
February 2, 2023 — Five additional imaging centers across Allegheny Health Network (AHN) have been recognized by the ...
January 31, 2023 — Electronic cigarette (e-cigarette) users have greater lung inflammation than cigarette smokers and ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
December 14, 2022 — CytoSite Bio, a company developing precision imaging products that determine patient response to ...
December 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
November 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
According to a recent study from market research firm Graphical Research, the global imaging agents market size is set ...
Reporting produces the tangible work product of diagnostic radiologists. Reports should reflect the expertise of the ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
October 25, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
October 24, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...
October 20, 2022 — A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B ...
October 19, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
October 17, 2022 — At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly ...
September 28, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
September 28, 2022 — Xoran Technologies is engaged in a ground-breaking research project to develop a PET/CT scanner for ...
September 13, 2022 — For over 40 years the vision of Shared Medical Services (SMS) has been to provide innovative ...